ExploreWatchlistsPricing
  1. JP-listed companies
  2. KOKANDO CO.,LTD.
  3. Financials
  4. Repurchases of common stock

KOKANDO CO.,LTD. (E00959)

Market cap
P/E ratio
Kokan-do manufactures over-the-counter medicines like cold and stomach remedies, blending Toyama's traditional medicine heritage with modern pharmaceutical operations.
SummaryFinancialsDividendsHistoryWorkforce
Period EndRepurchases of common stock (Million JPY)YoY (%)
Mar 31, 2025-1-61.07%
Mar 31, 2024-3-19.53%
Mar 31, 2023-3-83.65%
Mar 31, 2022-20+126.84%
Mar 31, 2021-9+29.34%
Mar 31, 2020-7-50.07%
Mar 31, 2019-14+15.68%
Mar 31, 2018-12+12.51%
Mar 31, 2017-10+8.97%
Mar 31, 2016-10-22.35%
Mar 31, 2015-12

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat